<DOC>
	<DOC>NCT00346190</DOC>
	<brief_summary>To determine whether administration of Alendronate early is more effective than late in the prevention of osteoporosis following a hip fracture</brief_summary>
	<brief_title>The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Male and Female aged &gt; 55 Low trauma hip fracture up to 90 days Be willing to submit to periodic bone mineral density radiographic studies of the spine &amp; 24 hr urine collection Written informed consent Disorders known to affect bone metabolism Not taking bisphosphonates within last 6 months Drugs known to interfere with calcium metabolism within the lats 6 months prior to hip fracture serum calcium&gt; 2.65 mmol/L Treatment with any investigational drug within the last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>